Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PFE -6.8% (guidance; also announces changes to its commercial ops following SGEN acquisition), LUV -2.6% (guidance)
Other news:
- SOS -3.3% (ADS offering)
- BDTX -2.8% (announces topline results from phase 1 dose escalation trial of BDTX-1535)
- TH -2.5% (announces details of $3.3 billion contract award for Pecos humanitarian community; updates 2023 guidance introduces 2024 guidance)
- XPEV -2.3% (BABA discloses a 12.5% passive stake)
Analyst comments:
- AVAH -4.7% (downgraded to Underweight from Neutral at JP Morgan)
- BFH -2.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- CHD -1.3% (downgraded to Sell from Neutral at Citigroup)
- RACE -1.3% (downgraded to Neutral from Outperform at Exane BNP Paribas; downgraded to Hold from Buy at HSBC Securities)
- COHR -1.1% (downgraded to Equal-Weight from Overweight at Morgan Stanley)